SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950103-19-001991
Filing Date
2019-02-14
Accepted
2019-02-13 20:37:04
Documents
2
Group Members
SHIRE HUMAN GENETIC THERAPIES, INC.SHIRE PLC

Document Format Files

Seq Description Document Type Size
1 FORM SC 13G dp102144_sc13g.htm SC 13G 62009
2 EXHIBIT 1 dp102144_ex9901.htm EX-99.1 6009
  Complete submission text file 0000950103-19-001991.txt   69662
Mailing Address 1-1, DOSCHOMACHI 4-CHOME CHUO-KU, OSALCA 540-8645 M0 00000
Business Address 1-1, DOSCHOMACHI 4-CHOME CHUO-KU, OSALCA 540-8645 M0 00000
TAKEDA PHARMACEUTICAL CO LTD (Filed by) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations

Mailing Address 29 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 29 HARTWELL AVENUE LEXINGTON MA 02421 617-945-7361
Translate Bio, Inc. (Subject) CIK: 0001693415 (see all company filings)

IRS No.: 611807780 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90547 | Film No.: 19600068
SIC: 2836 Biological Products, (No Diagnostic Substances)